Study will generate a key reference data set with Illumina Protein Prep solution SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The […]
Experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation takes helm at global genomics company CORALVILLE, Iowa and REDWOOD CITY, Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) has appointed Ajay Gannerkote as president, effective immediately. With a track record of driving growth and transformation across myriad […]
Collaboration combines Illumina’s sequencing technologies and Illumina Connected Software with NVIDIA tools to develop biological foundation models SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, […]
WALTHAM, Mass. & SAN DIEGO — Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity’s recent introduction of an automated next-generation sequencing (NGS) workflow […]
WALTHAM, Mass. & SAN DIEGO — Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity’s recent introduction of an automated next-generation sequencing (NGS) workflow […]
DALLAS — Almaden Genomics has announced g.nome® 2.0, a significant upgrade to its flagship platform to empower researchers and biologists with enhanced data analysis capabilities and streamlined workflows. These enhancements further the company’s mission to make bioinformatics tools more accessible, efficient, and powerful for the life sciences industry. Key among the new features is the introduction […]
Improved Metagenomics Classification, and Enhanced Long-Read Transcriptomics Pipelines We proudly present the OmicsBox Version 3.4 release that introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) […]
Strategic collaboration will introduce AI-enabled tools, optimized data sharing, bring your own cloud (BYOC) support, and enhanced scalability NEWTON, Mass. — The Broad Institute of MIT and Harvard today announced a strategic collaboration with Manifold, a leader in research infrastructure for biomedical science, to develop a cutting-edge research platform. This initiative expands on Broad’s vision for biomedical data analysis, secure sharing, and global […]
REDWOOD CITY, Calif. — Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to manufacture and distribute AstraZeneca’s novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide research community. This state-of-the-art nuclease, developed by AstraZeneca, will […]
The new Express License service removes barriers to accessing this transformative gene editing technology for startups. An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive internal research license. DUBLIN and CHESHIRE, United Kingdom — ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
